Dr. Hafron highlights the most significant prostate cancer treatment advances in 2022

Document Type

Multimedia

Publication Date

12-13-2022

Publication Title

Urology Times

Abstract

In this interview, Jason M. Hafron, MD, recaps the biggest advances in the prostate cancer treatment paradigm in 2022. Hafron is a partner at the Michigan Institute of Urology, PC; an associate professor of Urology at the William Beaumont School of Medicine, Oakland University; and the director of Robotic Surgery at Beaumont Hospital Royal Oak in Michigan.

Link to Full Text

Share

COinS